Parent Involvement in Adolescent Obesity Treatment

Korábbi kezelés

• Use of oral glucocorticoids, atypical antipsychotics, weight loss medications, or an investigational medication within 3 months of study participation
• Previous participation in HM20010365, HM20003076, HM20005235 or HM20014304
• Change in dose of metformin, tricyclic antidepressants, selective serotonin uptake inhibitors, or stimulant medications within 3 months of study participation
• Use of oral glucocorticoids, atypical antipsychotics, weight loss medications, or an investigational medication within 3 months of study participation
• Previous participation in HM20010365, HM20003076, HM20005235 or HM20014304

Más betegség

• Medical condition(s) that may be associated with unintentional weight change
• Diabetes mellitus
• Medical condition(s) that may be negatively impacted by exercise
• Psychiatric, cognitive, physical or developmental conditions that would impair the ability to complete assessments, participate in a group, or conduct physical activity
• Personal history of weight loss surgery
• Clinically significant eating disorder
• Admission to a psychiatric hospital within the past year
  • Parent Exclusion Criteria:
• Medical condition(s) that may be associated with unintentional weight change
• Psychiatric, cognitive, physical or developmental conditions that would impair the ability to complete assessments, participate in a group, or conduct physical activity
• Personal history of weight loss surgery
• Clinically significant eating disorder
• Change in dose of diabetes medications, tricyclic antidepressants, selective serotonin uptake inhibitors, or stimulant medications within 3 months of study participation
• Admission to a psychiatric hospital within the past year

Egyéb

• Adolescent Exclusion Criteria:
• Non-English speaking
• Use of a GLP-1 within 6 months of study participation
• Use of Depo-Provera within 6 months of study participation
• Reports of compensatory behaviors in the past 3 months
• Current pregnancy or plan to become pregnant during study period
• Current participation in another weight loss program
• Severe depression
• Non-English speaking
• Use of a GLP-1 within 6 months of study participation with no T2D diagnosis; if T2D diagnosis, change in dose GLP-1 within 3 months of study participation
• Use of Depo-Provera within 6 months of study participation
• Reports of compensatory behaviors in the past 3 months
• Current pregnancy, lactation, less than 6 months post-partum, or plan to become pregnant during study period
• Current participation in another weight loss program
• Severe depression

• Adolescent Inclusion Criteria:
• BMI ≥ 85th percentile for age and gender according to the CDC Growth Charts
• Age 12 to 16
• Must reside with the primary participating parent
  • Parent Inclusion Criteria:
• ≥18
• BMI ≥ 25 kg/m2
• Must reside with the adolescent